| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.6 | 1e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |